Jay Laver
jaylaver.bsky.social
Jay Laver
@jaylaver.bsky.social
Principal Investigator in Controlled Human Infection at the University of Southampton. Board game enthusiast and general nerd.
Reposted by Jay Laver
🔥🔥 Not an April Fool: my paper is on the *front cover* of @lancetmicrobe.bsky.social! 🤯🤯 New issue live today 🎉

Just look at that gorgeous diplococcus 😍🧫🦠👩‍🔬

Endless thanks to Chrissie Jones, Rob Read, @dbogaert.bsky.social @adamdale.bsky.social @jaylaver.bsky.social @bacterioskeptic.bsky.social
Our April issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #SARS-CoV-2 #COVID-19 #chikungunya #Neisseria #CHIM #mpox #BSI #Ecoli #Klebsiella #Mycoplasma

#IDSky #ClinMicro #OA
April 1, 2025 at 8:39 AM
Reposted by Jay Laver
Delighted to see our work with @who.int DRC MoH & @lshtm.bsky.social out @nejm.org

Performed largest ever evaluation rVSV-ZEBOV-GP for Ebola during 2018-20 outbreak.

In >200,000 individuals showed vaccine safe & offers significant protection.
They now represent cornerstone of response to Ebola.
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination | NEJM
At the beginning of the 2018–2020 outbreak of Ebola virus disease (EVD) in eastern Democratic Republic of Congo (DRC), no vaccine had been licensed. However, cluster-randomized evidence from Guinea...
www.nejm.org
December 19, 2024 at 10:50 AM
Reposted by Jay Laver
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season

✅ Just Accepted
#IDSky
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season
We hypothesized that response to infant pneumococcal conjugate vaccines (PCVs), administered during peak respiratory viral seasons could be blunted, particularly to higher carrier-load PCVs.
buff.ly
December 19, 2024 at 7:58 PM
Reposted by Jay Laver
@hicvac.bsky.social with Southampton Controlled Human Infection Group. Fantastic poster presentation by @alihill.bsky.social outlining T cell responses induced by the novel pertussis vaccine candidate, BPZE1 👏
November 29, 2024 at 6:33 PM
Reposted by Jay Laver
Fantastic view of Liverpool from the @hicvac.bsky.social conference venue. Looking forward to another day of talks today!
November 29, 2024 at 8:44 AM